An independent guide to cash-pay care. Every price is dated and sourced.

How we check
Wellchosen HealthSearch

What cash-pay care costs, and who to trust

Every price carries the date we checked it and its source, and every company we review is checked against FDA warning letters, BBB records and court filings.

Or go straight to the GLP-1 price tracker or care in your city

  • 68FDA warning letters tracked
  • 58companies checked
  • 55metro areas covered
Self-pay prices, by the monthChecked Oct 17, 2026
  1. Zepbound vial or KwikPenLillyDirect$299 to $449 [1]a month, by dose$449 for 7.5 to 15 mg needs a refill within 45 days [1]
  2. Wegovy penNovoCare Pharmacy$349 [2]a month$199 for the first two fills of 0.25 or 0.5 mg through Dec 31, 2026 [2]
  3. Wegovy pillNovoCare Pharmacy$149 to $299 [2]a month, by dose
  4. Foundayo pillLillyDirect$149 to $299 [3]a month, by dose
  5. OzempicNovoCare Pharmacy$349 to $499 [4]a monthApproved for type 2 diabetes, not weight loss [4]
  6. Medicare GLP-1 BridgePart D, if you qualify$50 [5]copay a monthRuns Jul 1, 2026 to Dec 31, 2027 [6]

Every channel and dose in the GLP-1 price tracker

Choose the care you are paying for

Prices, hidden costs and what to check before you pay, by type of care.

  • Weight loss and GLP-1s

    Zepbound, Wegovy, the new pills, compounded versions and online programs, compared on price and record.

    Brand self-pay from $149 a month [2] [3]

  • Menopause hormone therapy

    Estrogen and progesterone options, online programs and what they cost.

    FDA approved label changes that drop some boxed warning language [9] [10]

  • Testosterone therapy

    TRT clinics, online programs, enclomiphene and what the label says about blood pressure.

    Class-wide label changes in February 2025 [11]

  • Concierge medicine

    Membership fees and what they cover. Medicare does not pay the membership fee [12].

    MDVIP fees we read: $2,250 to $2,930 a year [13] [14]

  • Direct primary care

    A flat monthly fee for primary care, and how it works with an HSA.

    Typically $50 to $100 a month, per the AAFP [15]

  • Longevity testing

    Lab memberships, full body MRI, calcium scores and biological age tests, with what the evidence says.

    Function Health $365 a year [16]; Prenuvo MRI $2,499 [17]

  • Wellness injections

    NAD+, B12, sermorelin and other shots: FDA status, what compounded means, and what is known.

  • Executive physicals

    What hospital and private programs include, and which publish a price.

Compare GLP-1 programs at a glance

Eight telehealth programs, side by side: what they charge, what they sell, whether they name their pharmacy and whether FDA has sent them a warning letter. Each row links to the full review with sources and dates.

CompanyOur verdictPriceWhat it sellsPharmacyFDA warning letter
FoundClean$169 per 28 daysCompounded and brandNot namedNone found
Henry MedsCleanFrom $179 a monthSemaglutide and moreNot namedNone found
PlushCare weight lossClean$19.99/mo plus drugNo compounded drugsYour own pharmacyNone found
Ro (Ro Body Program)Clean$74 to $149 a month plus drugBrand drugs onlyNot namedNone found
IVIM HealthUse caution$117 a month prepaidCompounded drugsNot namedYes, Feb 20, 2026
EdenAvoid$99 a monthCompounded and brand"State-licensed"Yes, Jun 8 2026
Hims weight lossAvoid$149 plus drugBrand GLP-1sNot namedYes, Sep 9 2025
TrimRxAvoidFrom $199 a monthCompounded drugsNot namedNone found

Sorted by verdict, then name. No company pays for its place in this table or for its verdict. See every review by verdict

How we check a company

Every company gets the same test, whether or not it could ever pay us.

  1. 1

    Read the price where it is sold

    We take each price from the company's or drugmaker's own page, write down the date, and list what it leaves out: visits, labs, shipping and dose step-ups.

  2. 2

    Check the record

    We search FDA warning letters, BBB profiles, court filings and FTC actions before we write a review.

  3. 3

    Apply one rule

    Live claims FDA cited, a BBB Pattern of Complaints alert, a regulator or court finding, or peptides that cannot be compounded means Avoid. We never link to a company rated Avoid.

Where our reviews stand

  • Clean36No FDA letter, BBB complaint alert or regulator action found.
  • Use caution7A past FDA letter whose cited claims were fixed, and a reasonable record.
  • Avoid10Fails the rule. No links, whatever the company pays.
  • Not yet rated5Not enough confirmed to rate yet, so no links.

See every review by verdict

FDA warning letters, tracked

On Mar 3, 2026, FDA announced warning letters to 30 telehealth companies over how they marketed compounded GLP-1s [7]. Our tracker lists each letter with what FDA cited and links to the letter itself. The newest went to Empower Pharmacy, a large compounding pharmacy [8].

Open the letter tracker

  1. Sep 18, 2026Empower Clinic Services, LLC dba Empower PharmacyRead the letter on fda.gov
  2. Aug 24, 2026Peptide Partners LLCRead the letter on fda.gov
  3. Aug 24, 2026Royal Peptides LLCRead the letter on fda.gov

Find care in your city

Local guides with county health data, state Medicaid rules and the state medical board for each metro.

See all cities and care types

Questions people ask

Is Wellchosen Health a medical provider?

No. Wellchosen Health is an independent consumer guide. It does not prescribe, sell or ship any drug or treatment, and nothing on the site is medical advice. For care, talk with a licensed clinician. In an emergency, call 911.

How much does Zepbound cost without insurance?

Through LillyDirect, Zepbound costs $299 a month for 2.5 mg, $399 for 5 mg and $449 for 7.5 to 15 mg when refilled within 45 days, as a vial or KwikPen, checked Oct 17, 2026 [1]. Outside that window the price is $499 for 7.5 mg and $699 for 10 to 15 mg [1].

What is the cheapest brand GLP-1 without insurance?

On Oct 17, 2026, the lowest maker prices were $149 a month for the starting doses of the Wegovy pill [2] and Foundayo [3], and $199 for the first two fills of the 0.25 or 0.5 mg Wegovy pen through Dec 31, 2026 [2]. Higher doses cost more.

How does Wellchosen Health make money?

Two ways: affiliate links to some telehealth companies, which are placeholders until we join those programs, and labeled Sponsored placements for local practices on city pages, from $300 a month. Companies rated Avoid or Not yet rated never get affiliate links, and payment never changes a verdict. Details are on how we make money.

How do you decide a company is rated Avoid?

A company is rated Avoid if it has an FDA warning letter whose cited claims are still live, a BBB Pattern of Complaints alert, a regulator, state board or court finding against it, or it sells peptides that cannot legally be compounded. Use caution means a past FDA letter with the claims fixed and no Avoid trigger. A BBB letter grade alone does not set a verdict, but we always show it. Clean means none of these. The full rule is in our editorial standards.

Has a doctor reviewed these pages?

Not yet. Pages are written by the Wellchosen Health editorial team from FDA labels, peer-reviewed trials and government data. Each page shows "Medical review: pending" until a named licensed clinician reviews it. Our medical review policy explains how a reviewer will be added.

Sources

17 cited
  1. Zepbound self-pay prices. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  2. Wegovy self-pay offer. Novo Nordisk (NovoCare Pharmacy), Oct 17, 2026.
  3. Foundayo self-pay prices. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  4. Ozempic self-pay prices. Novo Nordisk (NovoCare Pharmacy), Oct 17, 2026.
  5. Weight loss drugs coverage. Medicare.gov (CMS), Oct 17, 2026.
  6. Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, Oct 17, 2026.
  7. FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s. U.S. Food and Drug Administration, Mar 3, 2026.
  8. Warning letter: Empower Clinic Services, LLC dba Empower Pharmacy. U.S. Food and Drug Administration, Sep 18, 2026.
  9. Fact sheet: FDA initiates removal of black box warnings from menopausal hormone replacement therapy products. U.S. Department of Health and Human Services, Nov 10, 2025.
  10. FDA approves labeling changes for menopausal hormone therapy products. U.S. Food and Drug Administration, Feb 12, 2026.
  11. FDA issues class-wide labeling changes for testosterone products. U.S. Food and Drug Administration, Feb 28, 2025.
  12. Concierge care. Medicare.gov (CMS), Oct 17, 2026.
  13. Mayy Deadrick, MD (MDVIP physician page). MDVIP, Oct 17, 2026.
  14. Brooke J. Nevins, MD (MDVIP physician page). MDVIP, Oct 17, 2026.
  15. Direct primary care. American Academy of Family Physicians, Oct 17, 2026.
  16. Function Health pricing. Function Health, Oct 17, 2026.
  17. Prenuvo pricing. Prenuvo, Oct 17, 2026.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.